Skip to content

HealthDeveloping

Health agencies submit peptide access policy to White House for review

By

Coverage spectrum

Covered by 4 outlets, mostly right-leaning (75%).

4 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

According to a government filing, the Department of Health and Human Services submitted a peptide interim access policy to the White House for review. The filing reportedly would let compounding pharmacies temporarily produce and sell certain peptides that were previously restricted. Some reports say the Food and Drug Administration sent the policy and that it follows the agency’s approval of six peptide drugs this summer. The policy is under review at the White House Office of Management and Budget, and no decision has been reported.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

  1. The Department of Health and Human Services submitted a peptide interim access policy to the White House Office of Management and Budget for review, according to a government filing.

    Reported byCenter1Right1Far Right2See the outletsHide the outlets
    Center
    The Hill
    Right
    The Washington Times
    Far Right
    The Epoch Times, The Daily Caller

  2. The proposed policy would let compounding pharmacies temporarily produce and sell certain peptides that were previously restricted.

    Reported byCenter1Right1Far Right2See the outletsHide the outlets
    Center
    The Hill
    Right
    The Washington Times
    Far Right
    The Epoch Times, The Daily Caller

  3. The submission reportedly follows the Food and Drug Administration’s approval of six peptide drugs this summer.

    One outletThe Daily Caller· Far Right

How each side tells it

Compare views

All four outlets report that HHS and the FDA submitted a peptide interim access policy to the White House for review, which would let compounding pharmacies temporarily sell certain peptides. The Hill leads with the FDA; right-side outlets emphasize Kennedy and his priority push.

  • the left

    No coverage yet

    No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

  • the center

    1 outlet

    Headline presents the FDA as advancing a peptide push to the White House, with pharmacy access for peptides in the description.

    FDA advances peptide push to White House
    The HillCenterAll center headlines

  • the right

    3 outlets

    Right-side headlines name Robert F. Kennedy Jr. or HHS and frame it as a plan sent or pushed to the White House; the Washington Times keeps to a plain HHS proposal.

    RFK Jr.’s Priority Plan To Put Peptides In Pharmacies Loaded verb“Pushed”The verb frames the submission as forced forward rather than sent, adding a sense of pressure the facts do not state.More neutral: sentDisagree with this highlight? To White House
    The Daily CallerFar RightAll right-leaning headlines

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

  • Left

    Has not covered this story.

  • Center0

    No loaded words in its own voice.

  • Right2

    alternative medicinePushed

In the outlets’ own words

  • Delegitimizing label

    alternative medicineMore neutral: a compounded peptide drug

    The label presents a contested classification of peptide drugs as settled and implies they lack standing.

    A requested policy for adopting an alternative medicine is slotted for approval pending permission from the White House.

    Used byThe Daily Caller (Far Right)

  • Loaded verb

    PushedMore neutral: sent

    The verb frames the submission as forced forward rather than sent, adding a sense of pressure the facts do not state.

    RFK Jr.’s Priority Plan To Put Peptides In Pharmacies Pushed To White House

    Used byThe Daily Caller (Far Right)

See the full language guide

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

0 outlets

No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

From the center

1 outlet

Leads with

  • FDA submission to White House
  • temporary pharmacy compounding
  • pending government review
See the headline from the centerHide the headlines
  • The HillCenter

    FDA advances peptide push to White House

    Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a …

    Read at The Hill (opens in a new tab)

From the right

3 outlets

Leads with

  • Kennedy’s personal priority
  • pharmacy access for peptides
  • White House review
See the 3 headlines from the rightHide the headlines

Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Who reported it when

How the coverage built up

  • Left

    No report yet

    From the outlets Mantle follows

  • Center

    2 hr 37 min later

    Its first report, Oct 15, 7:50 PM EDT

  • Right

    First to report

    The Epoch Times, Oct 15, 5:13 PM EDT

See the order the outlets reported inHide the order
  1. The Epoch TimesFar RightOct 15, 5:13 PM EDT
  2. The HillCenterOct 15, 7:50 PM EDT
  3. The Washington TimesRightOct 16, 10:22 AM EDT
  4. The Daily CallerFar RightOct 16, 5:13 PM EDT

Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.

Read next

Help someone else find the truth beneath the surface

Most people see one side of a story. Share this one, so they can see how every side is telling it and decide for themselves.

Email it

Seen a mistake? Tell us what is wrong with this page